Sfoglia per Autore

Opzioni
Mostrati risultati da 1 a 20 di 78
Titolo Data di pubblicazione Autori
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 1-gen-1993 Cazzaniga, MPiperno, A +
Adjuvant systemic treatment of early breast cancer: the NORA study 1-gen-2006 Cazzaniga M +
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study 1-gen-2007 Cazzaniga M +
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) 1-gen-2008 Arnoffi, JColombo, IVilla, FDapretto, ECazzaniga, MGardani, GBidoli, P +
Targeted therapies for the treatment of breast cancer in the post-trastuzumab era 1-gen-2008 Cazzaniga M +
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study 1-gen-2008 Cazzaniga M +
Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer 1-gen-2010 Bidoli PCazzaniga ME +
Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA study 1-gen-2011 Cazzaniga M +
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients 1-gen-2012 Cavaletti, GAAlberti, PCortinovis, DCazzaniga, M +
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 1-gen-2012 ALBERTI, PAOLACazzaniga, MCAVALETTI, GUIDO ANGELO +
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose 1-gen-2012 ALBERTI, PAOLACORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENABIDOLI, PAOLOCAVALETTI, GUIDO ANGELO
Major issue in chemotherapy-induced peripheral neuropathy (cipn): lack of standardized measurement scales. ciperinoms study: validity and reliability in cipn assessment 1-gen-2012 CORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENACAVALETTI, GUIDO ANGELOALBERTI, PAOLABidoli, P +
When progressive dysphagia could be related to an “old friend” – a case report 1-gen-2012 ALBERTI, PAOLACORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENABIDOLI, PAOLOFERRARESE, CARLO +
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study. 1-gen-2012 ALBERTI, PAOLACAZZANIGA, MARINA ELENACORTINOVIS, DIEGO LUIGICAVALETTI, GUIDO ANGELO +
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study 1-gen-2013 CAVALETTI, GUIDO ANGELOALBERTI, PAOLACazzaniga, M +
Clinical pattern and associations of oxaliplatin acute neurotoxicity: A prospective study in 170 patients with colorectal cancer 1-gen-2013 CAVALETTI, GUIDO ANGELOALBERTI, PAOLACazzaniga, M +
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study 1-gen-2013 Cavaletti, GAlberti, PCortinovis, DCazzaniga, ME +
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 1-gen-2013 CAVALETTI, GUIDO ANGELOALBERTI, PAOLAFRIGENI, BARBARACazzaniga, M +
Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centers 1-gen-2013 Cazzaniga M +
Long-term course of oxaliplatin-induced polyneuropathy: a prospective two-year follow-up study 1-gen-2014 ALBERTI, PAOLACORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENACAVALETTI, GUIDO ANGELO +
Mostrati risultati da 1 a 20 di 78
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile